CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Cash flows from operating activities:
Net loss	$ (80,298)	$ (34,567)	$ (55,461)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:
Depreciation and amortization	34,745	26,584	24,210
Impairment charges	5,686
Equity-based compensation	11,608	8,708	2,631
Paid-in-kind interest added to debt principal			295
Provision for credit losses	2,316	979	1,790
Amortization of deferred financing fees included in interest expense	3,224	3,517	1,726
Write-off of unamortized deferred financing fees			4,296
Loss on debt extinguishment			1,580
(Gain) loss on disposal of property, plant and equipment	(1,722)	1,153	935
Mark-to-market adjustments	(4,622)	(104)	3,502
Change in fair value of warrant liabilities	(7,015)	(10,207)	29,675
Foreign currency transactions	598	1,864	667
Deferred income tax expense (benefit)	3,287	(6,512)	(2,037)
Other	1,257	2,486	1,204
Change in operating assets and liabilities:
Accounts receivable	(2,766)	1,688	(16,789)
Inventories	(6,558)	915	(46,770)
Derivative assets and liabilities	16,383	6,440	(22,937)
Prepaid expense and other assets	1,983	(1,890)	(15,476)
Accounts payable	5,693	(59,292)	27,646
Accrued liabilities and other	2,958	(5,826)	2,685
Net cash used in operating activities	(13,243)	(64,064)	(56,628)
Cash flows from investing activities:
Additions to property, plant and equipment	(159,625)	(164,611)	(63,261)
Additions to intangible assets	(173)	(173)	(167)
Acquisition of business, net of cash acquired		(2,392)	(14,885)
Acquisition of equity method investments and non-marketable securities		(1,385)
Proceeds from sale of property, plant and equipment	13,875	206	4,144
Net cash used in investing activities	(145,923)	(168,355)	(74,169)
Cash flows from financing activities:
Payments on debt	(181,242)	(199,196)	(438,571)
Proceeds from debt	278,141	258,490	328,539
Payments on supply chain financing program	(163,869)	(32,141)
Proceeds from supply chain financing program	164,631	110,217
Proceeds from convertible notes payable	22,000
Proceeds from convertible notes payable - related party	50,000
Proceeds from related party debt			11,700
Debt extinguishment costs			(1,580)
Payment of debt issuance costs	(3,329)	(3,158)	(6,007)
Payment of convertible notes payable issuance costs	(511)
Proceeds from de-SPAC merger and PIPE financing			255,737
Net proceeds from (repayments of) repurchase agreements	(7,706)	(6,268)	14,588
Proceeds from exercise of stock options	12	848	375
Proceeds from exercise of Public Warrants		2,632
Proceeds from issuance of common stock	635	118,767
Common equivalent preferred dividends			(4,380)
Payment of equity issuance costs	(10)	(1,000)	(23,998)
Payment of preferred equity issuance costs			(1,250)
Payment for purchase of non-controlling interest		(2,000)
Payment for taxes for net share settlement of equity awards	(2,122)	(2,977)	(477)
Net cash provided by financing activities	156,630	244,214	134,676
Effect of exchange rate changes on cash	260	(360)	(344)
Net (decrease) increase in cash and cash equivalents and restricted cash	(2,276)	11,435	3,535
Cash and cash equivalents and restricted cash at beginning of period	37,840	26,405	22,870
Cash and cash equivalents and restricted cash at end of period	35,564	37,840	26,405
Supplemental non-cash investing and financing activities:
Property, plant and equipment acquired but not yet paid	32,582	23,124	8,811
Supplemental cash flow information:
Cash paid for interest	37,552	29,446	30,448
Cash paid for income taxes, net	$ 411	$ 1,432	$ 814